Ing Groep Nv Bristol Myers Squibb CO Transaction History

Ing Groep Nv

$16.5 Billion
Q3 2024

A detailed history of Ing Groep Nv transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ing Groep Nv holds 1,034,653 shares of BMY stock, worth $59.8 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

1,034,653

Previous 161,501 540.65%

Holding current value

$59.8 Million

Previous $6.71 Million 698.32%

% of portfolio

0.32%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$39.66 - $51.75 $34.6 Million - $45.2 Million	873,152 Added 540.65%	1,034,653 $53.5 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $6.47 Million - $8.52 Million	-160,830 Reduced 49.9%	161,501 $6.71 Million
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $7.95 Million - $9.02 Million	-165,741 Reduced 33.96%	322,331 $17.5 Million
Q4 2023 Feb 08, 2024	BUY	$48.48 - $57.85 $12.3 Million - $14.7 Million	253,553 Added 108.12%	488,072 $25 Million
Q3 2023 Oct 27, 2023	SELL	$57.89 - $64.73 $87.2 Million - $97.5 Million	-1,505,836 Reduced 86.52%	234,519 $13.6 Million
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $109 Million - $121 Million	1,707,308 Added 5166.3%	1,740,355 $111 Million
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $10.9 Million - $12.4 Million	-166,261 Reduced 83.42%	33,047 $2.29 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $949,132 - $1.12 Million	-13,860 Reduced 6.5%	199,308 $14.3 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $1,172 - $692,789	9,016 Added 4.42%	213,168 $15.2 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $7.34 Million - $8.08 Million	-101,071 Reduced 33.11%	204,152 $15.7 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $31.9 Million - $38.3 Million	-519,480 Reduced 62.99%	305,223 $22.3 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $25.3 Million - $29.5 Million	471,104 Added 133.23%	824,703 $51.4 Million
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $10.1 Million - $11.8 Million	170,082 Added 92.68%	353,599 $20.9 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $2.05 Million - $2.23 Million	33,067 Added 21.98%	183,517 $12.3 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $893,601 - $1.01 Million	-15,059 Reduced 9.1%	150,450 $9.5 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $5.46 Million - $6.19 Million	94,562 Added 133.29%	165,509 $10.3 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $904,177 - $1 Million	15,744 Added 28.52%	70,947 $4.28 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $2.69 Million - $3.15 Million	-49,107 Reduced 47.08%	55,203 $3.25 Million
Q1 2020 May 06, 2020	SELL	$46.4 - $67.43 $5.45 Million - $7.91 Million	-117,373 Reduced 52.95%	104,310 $5.81 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $4.03 Million - $5.26 Million	81,870 Added 58.56%	221,683 $14.2 Million
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $2.08 Million - $2.46 Million	48,540 Added 53.18%	139,813 $7.09 Million
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $262,187 - $289,921	5,876 Added 6.88%	91,273 $4.14 Million
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $9.66 Million - $11.5 Million	-214,143 Reduced 71.49%	85,397 $4.07 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $1.44 Million - $1.87 Million	-29,530 Reduced 8.97%	299,540 $15.6 Million
Q3 2018 Nov 06, 2018	BUY	$55.19 - $62.25 $4.58 Million - $5.16 Million	82,928 Added 33.69%	329,070 $20.4 Million
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $9.74 Million - $12.1 Million	-192,810 Reduced 43.93%	246,142 $13.6 Million
Q1 2018 May 07, 2018	BUY	$59.92 - $68.98 $12.3 Million - $14.1 Million	204,603 Added 87.31%	438,952 $27.8 Million
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $2.6 Million - $2.84 Million	-43,432 Reduced 15.64%	234,349 $14.4 Million
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $15.3 Million - $17.7 Million	277,781	277,781 $17.7 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account